Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.06 USD | +1.20% | +5.72% | +23.42% |
May. 13 | Oppenheimer Adjusts Achieve Life Sciences Price Target to $11 From $18, Maintains Outperform Rating | MT |
May. 09 | Transcript : Achieve Life Sciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.42% | 171M | |
+42.97% | 50.93B | |
-0.38% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+13.10% | 26.02B | |
-21.87% | 18.9B | |
+7.66% | 13.21B | |
+24.06% | 12.17B | |
+30.18% | 12.16B |
- Stock Market
- Equities
- ACHV Stock
- News Achieve Life Sciences, Inc.
- Transcript : Achieve Life Sciences, Inc., Q1 2024 Earnings Call, May 09, 2024